By Tony Fong

NEW YORK (GenomeWeb News) – Flush with cash, firms in the life science tools and molecular diagnostics spaces have embarked on stock buyback programs, signaling an end to a hoarding of cash and improving optimism about the state of the economy and their businesses.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."